Growth inhibition and apoptotic cell death in uterine cervical carcinoma cells induced by 5-fluorouracil

International Journal of Cancer

Volumn 71, Issue 4, 1997, Pages 668-674

  Ueda, Masatsugu ^a   Kumagai, Koji ^a   Ueki, Ken ^a   Tnoki, Chiharu ^a   Orino, Ichiro ^a   Ueki, Minoru ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; FAS ANTIGEN; FLUOROURACIL;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ANTIGENS, CD95; ANTIGENS, NEOPLASM; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; DNA FRAGMENTATION; FEMALE; FLOW CYTOMETRY; FLUOROURACIL; HUMANS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0030950349     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970516)71:4<668::AID-IJC25>3.0.CO;2-6     Document Type: Article

References (24)

1. BALL, C.R., POYNTER, R.W. and VAN DEN BERG, H.W., A novel method for measuring incorporation of radioactive precursors into nucleic acids and proteins of cells in monolayer culture. Anal. Biochem., 46, 101-107 (1972).
2. CORY, J.G., BRELAND, J.C. and CARTER, G.L., Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cells. Cancer Res., 39, 4905-4913 (1979).
3. EASTMAN, A., Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells, 2, 275-280 (1990).
4. GAVRIELI, Y., SHERMAN, Y. and BEN-SASSON, S.A., Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119, 493-501 (1992).
5. GORCZYCA, W., GONG, J. and DARZYNKIEWICZ, Z., Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res., 53, 1945-1951 (1993).
6. ITOH, N., YONEHARA, S., ISHII, A., YONEHARA, M., MIZUSHIMA, S., SAMESHIMA, M., HASE, A., SETO, Y. and NAGATA, S., The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell, 66, 233-243 (1991).
7. JAPAN SOCIETY OF OBSTETRICS AND GYNECOLOGY, The general rules for clinical and pathological management of uterine cervical cancer, p. 55, Kanehara Shuppan, Tokyo (1987).
8. KASAGI, N., GOMYO, Y., SHLRAI, H., TSUJITANI, S. and ITOH, H., Apoptotic cell death in human gastric carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. Jap. J. Cancer Res., 85, 939-945 (1994).
9. KAUFMANN, S.H., Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anti-cancer drugs: a cautionary note. Cancer Res., 49, 5870-5878 (1989).
10. KERR, J.F.R., WYLLIE, A.M. and CURRIE, A.R., Apoptosis: a basic biological phenomenon with wide-raneine implications in tissue kinetics. Brit. J. Cancer, 26, 239-257 (1972).
11. OBEID, L.M., LINARDIC, C.M., KAROLAK, L.A. and HANNUN, Y.A., Procrammed cell death induced by ceramide. Science (Wash.), 259, 1769-1771 (1993).
12. SPEARS, C.P., GUSTAVSSON, B.G., MITCHELL, M.S., SPICER, D., BERNE, M., BERNSTEIN, L. and DANENBERG, P.V., Thymidylate synthetase inhibition in malicnant tumors and normal liver of patients eiven intravenous 5-fluorouracfl. Cancer Res., 44, 4144-4150 (1984).
13. TRAUTH, B.C., KLAS, C., PETERS, A.M.J., MATZKU, S., MOLLER, P., FALK, W., DEBATIN, K.M. and KRAMMER, P.H., Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science (Wash.), 245, 301-305 (1989).
14. UEDA, M., UEKI, M. and SUGIMOTO, O., Characterisation of epidermal growth factor (EOF) receptor and biological effect of EGF on human uterine cervical adenocarcinoma cell line OMC-4. Hum. Cell, 6, 218-225 (1993).
15. UEDA, M., UEKI, M., YAMADA, T., OKAMOTO, Y., MAEDA, T., SUGIMOTO, O. and OTSUKI, Y. Scatchard analysis of EGF receptor and effects of EGF on growth and TA-4 production of newly established uterine cervical cancer cell line (OMC-1). Hum. Cell, 2, 401-410 (1989).
16. UEKI, M., OKAMURA, S. and MAEDA, T., Individualisation of patients for adjuvant chemotherapy after surgical treatment of cervical cancer. Brit. J. Obstet. Gymiecol., 94, 985-990 (1987).
17. WALKER, P.R., SMITH, C., YOUDALE, T., LEBLANC, J., WHITEIELD, J.F. and SIKORSKA, M., Topoisomerase 11-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res., 51, 1078-1085 (1991).
18. WlJSMAN, J.H., JONKER, R.R., KEIJZER, R., VAN DE VELDE, C.J.H., CORNELISSE, C.J. and VAN DIERENDONCK, J.H., A new method to detect apoptosis in paraffin sections: in situ end-labelins of fragmented DNA. J. Hisiochem. Cytochem., 41, 7-12 (1993).
19. WILKINSON, D.S. and PTTOT, H.C., Inhibition of ribosomal ribonucleic acid maturation in Novikoff hepatoma cells by 5-rluorouracil and 5-fluorouridine. J. biol. Chem., 248, 63-68 (1973).
20. WILLIAMS, G.T., Programmed cell death: apoptosis and oncogenesis. Cell, 65, 1097-1098 (1991).
21. WYLLIE, A.M., Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (Lond.), 284, 555-556 (1980).
22. WYLLIE, A.H., KERR, J.F. and CURRIE, A.R., Cell death: the significance of apoptosis. Int. Rev. Cytol., 68, 251-306 (1980).
23. WYLLIE, A.H., MORRIS, R.G., SMITH, A.L. and DUNLOP, D., Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macro molecular synthesis. J. Pathol., 142, 67-77 (1984).
24. YONEHARA, S., ISHII, A. and YONEHARA, M., A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. exp. Med., 169, 1747-1756 (1989).